Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stem cell therapy for ailing hearts

05.01.2005


Cord blood cells limit heart attack damage in animal study



Stem cells from umbilical cord blood effectively treated heart attacks in an animal study, report cardiologist Robert J. Henning, MD, and colleagues at the University of South Florida and James A. Haley Veterans’ Hospital.

When injected into rats’ hearts soon after a heart attack, stem cells taken from human umbilical cord blood (HUCB) greatly reduced the size of heart damage and restored pumping function to near normal. This improvement occurred without the need for drugs to prevent the rats’ immune system from rejecting the human cells.


The USF study will be published online this week in the journal Cell Transplantation, accompanied by an editorial discussing the progress of stem cell therapy in treating heart attacks, or myocardial infarctions.

If further animal studies and human clinical trials prove equally successful, the USF researchers suggest that stem cells from umbilical cord blood could be a new, widely applicable treatment for limiting or repairing the heart muscle destroyed when the vital organ’s blood supply is cut off. In the United States, nearly one of every 2 men and one of 3 women older than age 40 will suffer a heart attack, leaving them more vulnerable to chronic heart failure or another, potentially fatal, heart attack. Medications and bypass surgery have prolonged the lives of these patients, but many live with heart failure characterized by chronic fatigue and shortness of breath.

"Patients with heart failure due to heart attacks and other causes spend much of their day at home in a chair or in bed. These are the patients whose lives we hope to greatly improve with stem cell therapy to restore heart function," said Dr. Henning, lead author of the study.

"Our initial results are extremely promising, but raise questions about how these umbilical cord blood cells work. Are they transforming into new heart muscle cells or secreting growth factors that trigger the heart to repair itself? We need more research to insure such therapy will ultimately benefit patients with little or no side effects."

"The possibility to regenerate and to restore function of the heart after myocardial infarction with stem cell transplantation holds great promise for treating heart failure," writes David Stern, MD, dean of the Medical College of Georgia, and colleagues in the Cell Transplantation editorial accompanying the USF study. "Additional preclinical animal studies are warranted and should focus on examining the mechanisms that mediate the functional effects of stem cell transplantation."

The USF researchers compared HUBC-treated rats to both untreated rats (those receiving only a sugar water placebo) and control rats with normal hearts. The HUCB stem cells were injected directly into the heart muscle of rats an hour after heart attacks were induced. After four months of recovery, the size of scar tissue left by dead heart muscle was approximately three times smaller in the HUCB treated rats than in the untreated rats. As a result, the heart’s pumping capacity improved to near normal in the treated rats, after an initial decline, and was significantly greater than the cardiac function in the untreated rats with heart attacks.

"Scar tissue does not contract," Dr. Henning said. "Since scar tissue was minimized and more heart muscle remained in the treated rats, their hearts were able to function better as pumps."

The USF work adds to a growing field exploring the potential of stem cells to treat ailing hearts. Animal and human cell transplantation to treat heart attacks has focused primarily on immature cells harvested from adult bone marrow and skeletal muscle – with mixed results.

"Although not as primitive as human embryonic stem cells, stem cells isolated from infant’s cord blood are less mature than those taken from adult bone marrow and skeletal muscle," Dr. Henning said.

"Cord blood stem cells may be more amenable to repairing hearts. In addition, cord blood stem cells are readily accessible, easy to use, and, like adult stem cells, are not as controversial as embryonic stem cells." said coauthor Paul R. Sanberg, PhD, DSc, director of the USF Center of Excellence for Aging and Brain Repair.

The USF study does not define how the HUCB cells reduced acute heart attack damage in the rats, but the researchers continue to search for explanations. The researchers do not discount transdifferentiation -- that HUCB cells transform into functional heart muscle cells to regenerate damaged tissue. However, Dr. Henning suggests, these stem cells instead may release nourishing substances that rally primitive cells within the heart itself to form new blood vessels and muscle.

Other authors of the study were Hamdi Abu-Ali; MD; John Balis, MD; Michael B. Morgan, MD; and Alison E. Willing, PhD. The USF study was supported by the American Heart Association, the Veterans Administration, a Florida Biomedical Research Grant, and Saneron CCEL Therapeutics, Inc., a USF spin-out biotechnology company focusing on developing stem cell therapies for debilitating or deadly diseases. Some study authors are affiliated with Saneron and are co-inventors on related patent applications by USF.

Anne DeLotto Baier | EurekAlert!
Further information:
http://www.hsc.usf.edu

More articles from Life Sciences:

nachricht Scientists uncover the role of a protein in production & survival of myelin-forming cells
19.07.2018 | Advanced Science Research Center, GC/CUNY

nachricht NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Global study of world's beaches shows threat to protected areas

19.07.2018 | Earth Sciences

New creepy, crawly search and rescue robot developed at Ben-Gurion U

19.07.2018 | Power and Electrical Engineering

Metal too 'gummy' to cut? Draw on it with a Sharpie or glue stick, science says

19.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>